Taken together, these data provided evidences that SETBP1 was elevated in MDS with blasts ≥ 5% and higher-risk category, and promoted MDS cell proliferation, which contributing to the functions of METTL14 in MDS. This evidence concerns the gene METTL14 and myelodysplastic syndrome.